Oct 11, 2018 7:30 am EDT Acasti Pharma Announces Closing of $19.1 Million Underwritten Public Offering of Common Shares
Oct 4, 2018 9:35 am EDT Acasti Pharma Announces Pricing of $16.6 Million Underwritten Public Offering of Common Shares
Oct 3, 2018 4:23 pm EDT Acasti Pharma Announces Proposed Underwritten Public Offering of Common Shares
Oct 1, 2018 5:00 pm EDT Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under Debentures
Aug 29, 2018 4:05 pm EDT Acasti Pharma Announces the Election of Its Directors, Changes to Its Stock Option Plan and Other Related Matters Approved at Its AGM
Jul 31, 2018 5:09 pm EDT Acasti Pharma Announces Mailing of Management Information Circular and Amendment to Stock Option Plan